/People

Timothy Shannon

Investor

General Partner / East Coast at Canaan Partners

Westport, Connecticut

Writes $250K – $20M checks · typically $10M

Find your path to Timothy

Sign up to see every warm intro you have to Timothy

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Timothy. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Physician-turned-investor trained in pulmonary and critical care; former CuraGen CEO Tim Shannon founded and led Arvinas—pioneering targeted protein degradation—and often serves as board chair shaping scientific strategy and development plans.

Contact· self-published, not guessed

Invests in

BiotechConsumerDeep TechEnterprise SoftwareFintechHardwareHealthtech

Beyond investing

Boards
Shannon is a member of the Quality Assurance, Compliance and Safety Committee for the Yale Cancer Center.

From published sources — common ground for a warm intro.

Deals · 5

Vivace TherapeuticsBoard seat

via Canaan Partners · filed Mar 2025 · $35M raise

Rallybio HoldingsBoard seat

via Canaan Partners · filed May 2020 · $145.2M raise

NextCureBoard seat

via Canaan Partners · filed Nov 2018 · $93.4M raise

Arvinas Holding Co. LLCBoard seat

via Canaan Partners · filed Apr 2018 · $55M raise

Spyryx BiosciencesBoard seat

via Canaan Partners · filed Jul 2017 · $5M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Sources: the firm's website · SEC Form D filings · curated public sources.

Colleagues at Canaan Partners

Network1

Investors connected to Timothy in public investor directories — a warm-intro map.

Frequently asked questions

Who is Timothy Shannon?
Physician-turned-investor trained in pulmonary and critical care; former CuraGen CEO Tim Shannon founded and led Arvinas—pioneering targeted protein degradation—and often serves as board chair shaping scientific strategy and development plans.
Where does Timothy Shannon work?
Timothy Shannon is General Partner / East Coast at Canaan Partners.
What does Timothy Shannon invest in?
Timothy Shannon invests in Biotech, Consumer, Deep Tech, Enterprise Software, Fintech, Hardware, Healthtech.
What check size does Timothy Shannon write?
Timothy Shannon typically writes checks of $250K – $20M.
What boards does Timothy Shannon sit on?
Timothy Shannon holds tracked board seats at Aer Therapeutics, Arvinas Holding Co. LLC, Celldex Therapeutics, CytomX Therapeutics, NextCure, Rallybio Holdings, Spyryx Biosciences, Vivace Therapeutics.
What companies has Timothy Shannon invested in?
Investments tracked here include Vivace Therapeutics, Acesion Pharma ApS, Acesion Pharma ApS, Aer Therapeutics, Aer Therapeutics, Inc., Arvinas Holding Co. LLC, Civitas Therapeutics, CytomX Therapeutics, CytomX Therapeutics, Halda Therapeutics, Helix Therapeutics, Ideaya Biosciences, and 8 more.
Does Timothy Shannon lead rounds?
Yes — Timothy Shannon has led 1 tracked investment.

Founder mafias

About this profile. Compiled from public sources — Canaan Partners's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights